Filing Details

Accession Number:
0001567619-21-016869
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-08 20:48:16
Reporting Period:
2021-09-07
Accepted Time:
2021-09-08 20:48:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1704292 Zai Lab Ltd ZLAB Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1731790 Ying Du C/O Zai Lab Limited
4560 Jinke Road, Bldg 1, 4Th Floor
Pudong, Shanghai F4 201210
Chairwoman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2021-09-07 382 $143.25 1,038,056 No 4 S Direct
Ordinary Shares Disposition 2021-09-07 1,161 $146.73 1,036,895 No 4 S Direct
Ordinary Shares Disposition 2021-09-07 86 $147.90 1,036,809 No 4 S Direct
Ordinary Shares Disposition 2021-09-07 649 $148.97 1,036,160 No 4 S Direct
Ordinary Shares Disposition 2021-09-07 3,776 $150.05 1,032,384 No 4 S Direct
Ordinary Shares Disposition 2021-09-07 20,252 $151.10 1,012,132 No 4 S Direct
Ordinary Shares Disposition 2021-09-07 3,300 $151.83 1,008,832 No 4 S Direct
Ordinary Shares Disposition 2021-09-07 179 $152.75 1,008,653 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
  2. Reflects a weighted average sale price of $146.73 per share, at prices ranging from $146.41 to $147.32 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. Reflects a weighted average sale price of $147.90 per share, at prices ranging from $147.50 to $148.04 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  4. Reflects a weighted average sale price of $148.97 per share, at prices ranging from $148.52 to $149.37 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  5. Reflects a weighted average sale price of $150.05 per share, at prices ranging from $149.57 to $150.53 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  6. Reflects a weighted average sale price of $151.10 per share, at prices ranging from $150.58 to $151.57 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  7. Reflects a weighted average sale price of $151.83 per share, at prices ranging from $151.58 to $152.53 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.